0001213900-25-042848.txt : 20250514 0001213900-25-042848.hdr.sgml : 20250514 20250513195842 ACCESSION NUMBER: 0001213900-25-042848 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250514 DATE AS OF CHANGE: 20250513 EFFECTIVENESS DATE: 20250514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-546005 FILM NUMBER: 25942169 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA VIRGINIA 23060 (804) 487-8196 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true Cary J. Claiborne 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Director Chief Executive Officer Vinay Shah 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Chief Financial Officer James K. Anderson 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Robertson H. Gilliland 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director James W. Newman, Jr. 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Kevin W. Schuyler, CFA 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Tony Goodman 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Director Chief Operating Officer Pharmaceuticals Decline to Disclose 06b false 2025-05-02 false true true false 0 A.G.P./Alliance Global Partners 000005361 None None 590 Madison Avenue 28th Floor New York NY NEW YORK 10022 NY NEW YORK false 4815379 4815379 0 Consists of $0.74 per share that may be received upon future exercise of warrants to purchase up to 6,507,270 shares of common stock. true 1 0 true 0 0 true false ADIAL PHARMACEUTICALS, INC. /s/ Cary J. Claiborne Cary J. Claiborne Chief Executive Officer 2025-05-12